Stocks to Watch Today: TCS, Tata Elxsi, Anand Rathi, IREDA, Hindustan Unilever, Glenmark Pharma, Aegis Logistics, Meta Infotech in focus on 11 July- Grow Mudra

Stocks to Watch Today: TCS, Tata Elxsi, Anand Rathi, IREDA, Hindustan Unilever, Glenmark Pharma, Aegis Logistics, Meta Infotech in focus on 11 July

11 Jul , 2025 By : Debdeep Gupta

Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, acquisitions, and appointments, here’s a quick look at which stocks will be in focus in today's trade:

Results Today

Avenue Supermarts, Aditya Birla Money, Droneacharya Aerial Innovations, Elecon Engineering Company, Emerald Finance, Jagsonpal Finance & Leasing, Nath Bio-Genes (India), and Astonea Labs will announce quarterly earnings scorecard on July 11.

Quarterly Earnings

Tata Consultancy Services Q1 (Consolidated YoY)

Profit grows 6% to Rs 12,760 crore Vs Rs 12,040 crore

Revenue increases 1.3% to Rs 63,437 crore Vs Rs 62,613 crore

Revenue declines 3.1% in constant currency

Operating income rises 0.5% to Rs 15,514 crore Vs Rs 15,442 crore

EBIT margin drops to 24.5% Vs 24.66%

Company announces dividend of Rs 11 per share

Total contract value (TCV) at $9.4 billion

Tata Elxsi Q1 (YoY)

Profit falls 21.6% to Rs 144.4 crore Vs Rs 184 crore

Revenue declines 3.7% to Rs 892.1 crore Vs Rs 926.5 crore

Indian Renewable Energy Development Agency IREDA Q1 (Consolidated YoY)

Profit tanks 35.7% to Rs 246.9 crore Vs Rs 383.7 crore

Revenue zooms 29% to Rs 1,947.6 crore Vs Rs 1,510.3 crore

Impairment on financial instruments stands at Rs 362.6 crore Vs writeback at Rs (30.04) crore

Anand Rathi Wealth Q1 (Consolidated YoY)

Profit surges 27.9% to Rs 93.9 crore Vs Rs 73.4 crore

Revenue grows 15.3% to Rs 274 crore Vs Rs 237.6 crore

Stocks to Watch

Hindustan Unilever

Rohit Jawa will step down as the Managing Director & Chief Executive Officer (MD & CEO) of the company, effective July 31. The Board has appointed Priya Nair as the MD & CEO for a term of five consecutive years, effective August 1.

Glenmark Pharmaceuticals

IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), and AbbVie have announced an exclusive licensing agreement for IGI’s lead investigational asset, ISB 2001. The drug was developed using IGI’s proprietary BEAT protein platform for oncology and autoimmune diseases.

Under the agreement, AbbVie will receive exclusive rights to develop, manufacture, and commercialize ISB 2001 across North America, Europe, Japan, and Greater China. Subject to regulatory clearance, IGI will receive an upfront payment of $700 million and is eligible to receive up to $1.225 billion in development, regulatory, and commercial milestone payments, along with tiered, double-digit royalties on net sales. Ichnos Glenmark Innovation (IGI) is a strategic alliance between Glenmark Pharma and Ichnos Sciences Inc.

Aegis Logistics

The company has transferred its liquified petroleum gas (LPG) terminal, with cryogenic static storage capacity of 48,000 MT at Pipavav, to Aegis Vopak Terminals via a slump sale on a going concern basis for Rs 428.4 crore.

Zee Entertainment Enterprises

Zee Entertainment Enterprises failed to secure the required shareholder votes to raise funds by issuing warrants, blocking plans by the founding Goenka family to increase their stake in the broadcaster. Only 59.5% of participating shareholders supported the resolution—falling short of the 75% majority required for approval, according to a report by Reuters.

SBI Cards and Payment Services

Shantanu Srivastava has resigned as Chief Risk Officer of the company, effective October 6, 2025, due to personal reasons.

JB Chemicals & Pharmaceuticals

The Board has appointed Richa Arora as an Independent Director of the company.

Centrum Capital

The Board of Directors will meet on July 15 to consider a proposal for raising funds via the issuance of equity shares or other eligible securities.

AiroLam

To utilise its enhanced capacity and tap into growing global demand, the company is expanding its international presence by incorporating overseas subsidiaries in Poland, the United States of America, and Dubai, United Arab Emirates.

Aspira Pathlab & Diagnostics

Shareholders have approved the re-appointment and remuneration of Pankaj Shah as Managing Director & CEO of the company for a term of three consecutive years, effective August 1, 2025.

International Travel House

The Board has approved the re-appointment of Ashwin Moodliar as Managing Director of the company for a period of two years, effective February 1, 2026. His current term ends on January 31, 2026.

Bulk Deals

Embassy Office Parks REIT

APAC Company XXIII sold 1.78 crore units at Rs 388 per unit, valued at Rs 691.4 crore.

Navkar Urbanstructure

Jupiter City Developers (India) has acquired an additional 75 lakh shares at Rs 2.02 per share.

SME IPO Listing on July 11

Meta Infotech

Stocks Trade Ex-Dividend

Apollo Tyres

Artemis Medicare Services

Atul

Balkrishna Industries